Nephrology

Home Nephrology

2021 KDIGO Guideline Lowers Target Systolic BP for Adults With CKD

69.5 percent of adults with CKD eligible for BP lowering according to 2021 KDIGO guideline versus 49.8 percent with 2012 guideline

Early Immunologic Biomarker Predicts Renal Allograft Outcomes

Ratio of IL-10/TNF╬▒ produced by T1B three months after renal transplantation predicts clinical, subclinical rejection during first year

One in Five Health Care Workers Reports Mental Health Conditions

Review shows high prevalence of depression, anxiety, and PTSD during the COVID-19 pandemic

Decline in Kidney Function Faster After COVID-19-Related AKI

Among patients who have in-hospital acute kidney injury, those with AKI tied to COVID-19 have faster rate of decrease in eGFR after discharge

Physical Activity May Improve Cardiorenal Outcomes in CKD

High physical activity level (7.5 to <15 MET hours/week) linked to lower risks for all-cause mortality, ESRD, MACE

Adding Measures of Kidney Function Helps Predict CVD Risk

Adding eGFR, urinary albumin-to-creatinine ratio increases C statistic for risk prediction in overall population, those with diabetes

Targeted Albumin Not Better for Hospitalized Cirrhosis Patients

No difference in incidence of end-point events, but more adverse events, seen in targeted albumin group versus standard-care group

Six in 10 Heart Failure Patients Readmitted Within One Year

Comorbidities, including kidney dysfunction, lung disease, and psychiatric illness, tied to higher readmission

Terlipressin Bests Placebo in Type 1 Hepatorenal Syndrome

Terlipressin is more effective for reversal of HRS but is associated with more adverse events and death due to respiratory disorders

Dysnatremia Tied to Poorer Prognosis in Hospitalized COVID-19 Patients

Hypernatremia linked to increased mortality, while hyponatremia at admission linked to increased odds of needing ventilatory support